www.tickerreport.com ·
Handelsbanken Fonder Ab Trims Holdings in Cellebrite Di Ltd Clbt
Topic context
This topic has been covered 370060 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe article reports institutional and insider selling of Cellebrite DI (CLBT) shares, indicating reduced confidence or profit-taking. The commercial mechanism is weak: no direct impact on product prices, supply, or margins. The sector is GLOBAL_TECH due to the company's technology focus, but no concrete commercial channel is identified.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Handelsbanken Fonder AB reduced its stake in Cellebrite DI Ltd. by 47.9% in Q4, selling 1,390,000 shares.
- Cellebrite DI's stock was trading at $13.46 as of May 20, 2026, down 1.2%.
- Market cap of Cellebrite DI is $3.36 billion.
- Insiders sold 13,269 shares in the last quarter, holding 5.70% of the company.
- Analysts have a consensus price target of $21.75 for CLBT.
Related stories
finance.yahoo.com
Kevin Warsh Confirmed Fed Chair
finance.yahoo.com
Shares Rally Nvidia Earnings Samsung
finance.yahoo.com
Stock Market Today Dow Sp 500 Nasdaq Futures Rise in Countdown to Nvidia Earnings
fool.com
Wow Fed May Inflation Forecast Update Ugly Wall St
finance.yahoo.com